Inogen, Inc.
INGNNASDAQHealthcare● Active
$6.17
$-0.24(-3.74%)
Market Cap$167057886
P/E Ratio—
52W High$9.13
52W Low$5.34
Inogen, Inc. (INGN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
INGN · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
-$0.30
Est. -$0.24 · -25.0%
Revenue
$0.09B
Est. $0.08B · +3.4%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
INGN reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | -$0.17 | — | — | — | $0.10B | — |
| ▼ Q2 FY2026 | May 7, 2026 | -$0.24 | -$0.30 | -25.0% | $0.09B | $0.08B | +3.4% |
| ▲ Q1 FY2026 | Feb 24, 2026 | -$0.36 | -$0.26 | +27.8% | $0.08B | $0.09B | -3.9% |
| ▲ Q4 FY2025 | Nov 5, 2025 | -$0.22 | -$0.20 | +9.1% | $0.09B | $0.09B | +4.3% |
| ▲ Q3 FY2025 | Aug 7, 2025 | -$0.22 | -$0.15 | +31.8% | $0.09B | $0.09B | -1.1% |
| ▲ Q2 FY2025 | May 7, 2025 | -$0.52 | -$0.25 | +51.9% | $0.08B | $0.09B | -11.3% |
| ▲ Q1 FY2025 | Feb 25, 2025 | -$0.56 | -$0.41 | +26.8% | $0.08B | $0.07B | +8.4% |
| ▲ Q4 FY2024 | Nov 7, 2024 | -$0.49 | -$0.25 | +49.0% | $0.09B | $0.07B | +20.2% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
-$0.17
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Miss
EPS Actual
-$0.30
EPS Est.
-$0.24
EPS Surpr.
-25.0%
Revenue
$0.09B
Q1 FY2026
Feb 24, 2026Beat
EPS Actual
-$0.26
EPS Est.
-$0.36
EPS Surpr.
+27.8%
Revenue
$0.08B
Q4 FY2025
Nov 5, 2025Beat
EPS Actual
-$0.20
EPS Est.
-$0.22
EPS Surpr.
+9.1%
Revenue
$0.09B
Q3 FY2025
Aug 7, 2025Beat
EPS Actual
-$0.15
EPS Est.
-$0.22
EPS Surpr.
+31.8%
Revenue
$0.09B
Q2 FY2025
May 7, 2025Beat
EPS Actual
-$0.25
EPS Est.
-$0.52
EPS Surpr.
+51.9%
Revenue
$0.08B
Q1 FY2025
Feb 25, 2025Beat
EPS Actual
-$0.41
EPS Est.
-$0.56
EPS Surpr.
+26.8%
Revenue
$0.08B
Q4 FY2024
Nov 7, 2024Beat
EPS Actual
-$0.25
EPS Est.
-$0.49
EPS Surpr.
+49.0%
Revenue
$0.09B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $-0.21 | $-0.21 | $-0.21 | 1 |
| Q3 FY2028 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q2 FY2028 | $-0.08 | $-0.08 | $-0.08 | 1 |
| Q1 FY2028 | $-0.21 | $-0.21 | $-0.21 | 1 |
| Q4 FY2027 | $-0.15 | $-0.14 | $-0.14 | 1 |
| Q3 FY2027 | $-0.04 | $-0.04 | $-0.04 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q1 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 7, 2026 | -25.0% | $7.11 | $7.19 | +1.13% |
| ▲ Q1 FY2026 | Feb 24, 2026 | +27.8% | $5.68 | $5.84 | +2.82% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +9.1% | $8.06 | $7.39 | -8.31% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +31.8% | $6.30 | $5.87 | -6.83% |
| ▲ Q2 FY2025 | May 7, 2025 | +51.9% | $7.07 | $7.17 | +1.41% |
| ▲ Q1 FY2025 | Feb 25, 2025 | +26.8% | $9.84 | $9.52 | -3.25% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +49.0% | $9.57 | $9.46 | -1.15% |
| ▲ Q3 FY2024 | Aug 6, 2024 | +56.4% | $8.18 | $8.15 | -0.37% |
Q2 FY2026+1.13%
Report Date
May 7, 2026
EPS Beat/Miss
-25.0%
Price Before
$7.11
Price After
$7.19
Q1 FY2026+2.82%
Report Date
Feb 24, 2026
EPS Beat/Miss
+27.8%
Price Before
$5.68
Price After
$5.84
Q4 FY2025-8.31%
Report Date
Nov 5, 2025
EPS Beat/Miss
+9.1%
Price Before
$8.06
Price After
$7.39
Q3 FY2025-6.83%
Report Date
Aug 7, 2025
EPS Beat/Miss
+31.8%
Price Before
$6.30
Price After
$5.87
Q2 FY2025+1.41%
Report Date
May 7, 2025
EPS Beat/Miss
+51.9%
Price Before
$7.07
Price After
$7.17
Q1 FY2025-3.25%
Report Date
Feb 25, 2025
EPS Beat/Miss
+26.8%
Price Before
$9.84
Price After
$9.52
Q4 FY2024-1.15%
Report Date
Nov 7, 2024
EPS Beat/Miss
+49.0%
Price Before
$9.57
Price After
$9.46
Q3 FY2024-0.37%
Report Date
Aug 6, 2024
EPS Beat/Miss
+56.4%
Price Before
$8.18
Price After
$8.15
Avg Beat Reaction-2.24%
Avg Miss Reaction+1.13%
Beat Rate7 / 8 quarters
Largest Move-8.31% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: INGN ends December
Inogen, Inc. (INGN) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $-0.30 — missing the analyst consensus of $-0.24 by -25.0%. The next INGN earnings date is expected around September 1, 2026.
Each quarter, investors track INGN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. INGN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
INGN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
INGN earnings · 5 questionsInogen, Inc.'s next earnings report is expected around September 1, 2026. INGN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; INGN historically reports after market close (AMC).
INGN earnings datewhen is INGN earningsINGN next earnings datewhen does INGN report earningsINGN earnings calendar
▸ Source: FMP · Inogen, Inc. SEC filings · US GAAP · Inogen, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026